Skip to main content
letter
. 2023 Jun 2;54:102599. doi: 10.1016/j.tmaid.2023.102599

Table 1.

Demographic, clinical, and paraclinical profiles of four patients confirmed with MPXV in Venezuela.

Patient 1 Patient 2 Patient 3 Patient 4
Demographics
Age, years 26 25 32 20
Clinics
No. of sexual partners in the last month 0 2 2 7
Maximum number of concurrent lesions 10–50 10–50 51–100 10–50
CD4 count N/A N/A N/A 577
HIV viral load, copies/mL Undetectable 161,000 Undetectable Undetectable
Smallpox vaccination history No No No No
Lesion morphology Vesicular Vesicular Vesicular Vesicular
Lesion resolution time, days 10 14 12 13
Complication None Proctitis None Penile ulcer
Outcome Full recovery Full recovery Full recovery Full recovery
Paraclinics
White blood cells, × 103/mL N/A 7.9 N/A 5.5
Neutrophils, × 103/mL N/A 5.21 N/A 2.86
Lymphocytes, × 103/mL N/A 2.21 N/A 1.27

N/A: not available.